|
⚲
|
| Watson Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000884629 |
| Sale | 2009-12-02 ($500.0 M Offered, $500.0 M Sold) |
| Fund | |
| Phone | 9092701400 |
| Address | 311 Bonnie Circle Corona, 92880 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-12-10 (D) |
| Exemption | 506 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Paul Bisaro | Executive Officer | |
| Jack Michelson | Director | |
| Catherine Klema | Director | |
| Michel Feldman | Director | |
| Fred Weiss | Director | |
| Michael Fedida | Director | |
| Anthony Tabatznik | Director | |
| Christopher Bodine | Director | |
| David Buchen | Executive Officer | |
| Albert Hummel | Director | |
| Andrew Turner | Director | |
| Ronald Taylor | Director | |
| R Todd Joyce | Executive Officer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Newtopia Investments I LLC
✚
|
0.0 | |
|
Nexgen Sports Group Inc
✚
|
0.0 | |
|
Neyland ELLA S
✚
|
0.0 | |
|
NHE Group LLC
✚
|
0.0 | |
|
NH Investments ET LLC
✚
|
0.0 | |
|
Niffenegger Kathi
✚
|
0.0 | |
|
Nissen Torben Straight
✚
|
0.0 | |
|
No Label Ventures I LP
✚
|
0.0 | |
|
Nola Rugby Enterprises LLC
✚
|
0.0 | |
|
Negev Labs LLC
✚
|
0.0 |